Latest debt-to-equity ratio
Taysha Gene Therapies Debt-to-equity ratio
Direct answer
Taysha Gene Therapies's debt-to-equity ratio is 14.65%.
The verified market snapshot reports 14.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 14.65%
Explore related company data
View Taysha Gene Therapies's market capitalizationView Taysha Gene Therapies's price-to-book ratioView Taysha Gene Therapies's return on equityView Taysha Gene Therapies's dividend yieldView Taysha Gene Therapies's 52-week price rangeView Taysha Gene Therapies's profit marginView all Taysha Gene Therapies key metricsReturn to Taysha Gene Therapies profile